GlassScriptPhysician profile
Denny Tang
NPI 1396783783
$9,576.61
in general payments reported to CMS, 2019-2025
14 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.10 · 2020: $67.13 · 2021: $57.19 · 2022: $1,108 · 2023: $2,767 · 2024: $3,522 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,118 · Travel and Lodging: $1,525 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,118.00 |
| Travel and Lodging | $1,525.35 |
| Food and Beverage | $603.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $7,413.57 | 2019-2024 | Esophyx |
| Stryker Corporation | $1,840.70 | 2025 | 1788 |
| Phathom Pharmaceuticals, INC. | $136.97 | 2024-2025 | Voquezna |
| Ethicon US, LLC | $27.15 | 2021 | |
| Kci USA, INC. | $21.50 | 2022 | |
| Exact Sciences Corporation | $17.68 | 2023 | Cologuard Collection Kit |
| Philips North America LLC | $16.32 | 2023 | |
| Cook Medical LLC | $15.55 | 2019 | |
| Coopersurgical, INC. | $15.11 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Acera Surgical, INC. | $15.01 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $14.74 | 2022 | |
| La Jolla Pharmaceutical Company | $14.50 | 2021 | |
| Braintree Laboratories, INC. | $14.26 | 2019 | |
| Thd America, INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denny Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.